Masimo's third-quarter 2024 results continue to benefit from the strength in its Healthcare business.
Vous n'êtes pas connecté
Clover Health's third-quarter 2024 results continue to benefit from the strength of its business model.
Masimo's third-quarter 2024 results continue to benefit from the strength in its Healthcare business.
MTZ's third-quarter results benefit from strength in the diversified business model and strong bookings of renewable energy projects.
FORM's third-quarter 2024 results benefit from record DRAM probe-card revenues on strong demand. Its weak guidance hurts shares.
FORM's third-quarter 2024 results benefit from record DRAM probe-card revenues on strong demand. Its weak guidance hurts shares.
URI's third-quarter results benefit from solid end markets and the strength of its core rental business. Yet, tepid Used equipment sales remain a...
CI's strong third-quarter results benefit from a strong Evernorth Health Services segment. Higher expenses partially offset the positives.
MKSI's third-quarter results reflect strength in the Semiconductor and Electronics & Packaging market amid sluggish Specialty Industrial demand.
TRU clocks significant y/y increases in its Financial Services and Consumer Interactive revenues in the third quarter of 2024.
MTCH's third-quarter results benefit from strength in Hinge direct revenues and downloads despite sluggish growth in total payers.
Omnicell continues its trend of impressive results in the third quarter of 2024.